| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1440-1789.2009.01017.X |
| P698 | PubMed publication ID | 19422539 |
| P2093 | author name string | Cynthia A Lemere | |
| Koichi Okamoto | |||
| Tsuneo Yamazaki | |||
| Ai Kadokura | |||
| Masamitsu Takatama | |||
| P433 | issue | 5 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 566-573 | |
| P577 | publication date | 2009-04-21 | |
| P1433 | published in | Neuropathology | Q15761930 |
| P1476 | title | Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology | |
| P478 | volume | 29 |
| Q24634907 | Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease |
| Q41688795 | Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation. |
| Q37207592 | Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy |
| Q34285952 | Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination |
| Q37833138 | Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome). |
| Q48456453 | Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q45873297 | Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration |
| Q34153412 | Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury |
| Q34071708 | Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders. |
| Q35244113 | Identification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-α expression upon lipopolysaccharide stimulation in human monocytes |
| Q34504310 | Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits |
| Q64385732 | Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. |
| Q35060401 | Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles |
| Q28070156 | Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? |
| Q35592875 | On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia |
| Q38915426 | Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi |
| Q34632269 | Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness |
| Q44359436 | Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease |
| Q34207044 | Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions |
| Q26863702 | Potential mechanisms of progranulin-deficient FTLD |
| Q34206962 | Probing the biology of Alzheimer's disease in mice |
| Q35512201 | Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration |
| Q37621617 | Staging TDP-43 pathology in Alzheimer's disease |
| Q36217832 | TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features |
| Q53420239 | TAR-DNA binding protein-43 and alterations in the hippocampus. |
| Q93210804 | TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study |
| Q37733168 | TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration |
| Q34566756 | TDP-43 in aging and Alzheimer's disease - a review |
| Q102369181 | TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer's disease |
| Q48864196 | TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype |
| Q38124396 | TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis |
| Q37315699 | TDP-43 pathology, cognitive decline, and dementia in old age |
| Q39331146 | TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia |
| Q90379423 | TDP-43: From Alzheimer's Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy |
| Q46251905 | The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases |
| Q38380370 | Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer's Disease: Common Pathologies Potentiated by Altered Zinc Homeostasis |
| Q48949710 | Updated TDP-43 in Alzheimer's disease staging scheme |
| Q35079027 | p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. |
Search more.